教室紹介

業績

Results

2017年

  1. Amer H, Niaz K, Hatazawa J, Gasmelseed A, Samiri HA, Al Othman M, Hammad MA. Future cardiac events in patients with ischemic ECG changes during adenosine infusion as a myocardial stress agent and normal cardiac scan. Nucl Med Commun. 2017 Sep 11.
  2. Wu R, Watanabe Y, Arisawa A, Takahashi H, Tanaka H, Fujimoto Y, Watabe T, Isohashi K, Hatazawa J, Tomiyama N. Whole-tumor histogram analysis of the cerebral blood volume map: tumor volume defined by 11C-methionine positron emission tomography image improves the diagnostic accuracy of cerebral glioma grading. Jpn J Radiol. 2017 Sep 6.
  3. Morita T, Tatsumi M, Ishibashi M, Isohashi K, Kato H, Honda O, Shimosegawa E, Tomiyama N, Hatazawa J. Assessment of Mediastinal Tumors Using SUV(max) and Volumetric Parameters on FDG-PET/CT. Asia Ocean J Nucl Med Biol. 2017 Winter;5(1):22-29.
  4. Mochida I, Shimosegawa E, Kanai Y, Naka S, Matsunaga K, Isohashi K, Horitsugi G, Watabe T, Kato H, Hatazawa J. Whole-Body Distribution of Donepezil as an Acetylcholinesterase Inhibitor after Oral Administration in Normal Human Subjects: A (11)C-donepezil PET Study. Asia Ocean J Nucl Med Biol. 2017 Winter;5(1):3-9.
  5. Miyabe J, Hanamoto A, Tatsumi M, Hamasaki T, Takenaka Y, Nakahara S, Kishikawa T, Suzuki M, Takemoto N, Michiba T, Yoshioka Y, Isohashi F, Konishi K, Ogawa K, Hatazawa J, Inohara H. Metabolic tumor volume of primary tumor predicts survival better than T classification in the larynx preservation approach. Cancer Sci. 2017 Aug 8.
  6. Sakane M, Tatsumi M, Hori M, Onishi H, Tsuboyama T, Nakamoto A, Ota T, Eguchi H, Wakasa K, Hatazawa J, Tomiyama N. Volumetric parameters of 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography/computed tomography can predict histopathologic treatment response after neoadjuvant chemoradiotherapy in pancreatic adenocarcinoma. Eur J Radiol. 2017 Jun 23. pii:S0720-048X(17)30200-0.
  7. Makino T, Yamasaki M, Tanaka K, Tatsumi M, Takiguchi S, Hatazawa J, Mori M, Doki Y. Importance of positron emission tomography for assessing the response of primary and metastatic lesions to induction treatments in T4 esophageal cancer. Surgery. 2017 Oct;162(4):836-845. doi: 10.1016/j.surg.2017.06.007.
  8. Kanoto M, Kirii K, Hiraka T, Toyoguchi Y, Sugai Y, Matsuda K, Sakurada K, Sonoda Y, Hatazawa J, Hosoya T. Correlation between hypoxic area in primary brain tumors and WHO grade: differentiation from malignancy using 18F-fluoromisonidazole positron emission tomography. Acta Radiol. 2017 Jan 1:284185117711474.
  9. Kishimoto A, Kataoka J, Taya T, Tagawa L, Mochizuki S, Ohsuka S, Nagao Y, Kurita K, Yamaguchi M, Kawachi N, Matsunaga K, Ikeda H, Shimosegawa E, Hatazawa J. First demonstration of multi-color 3-D in vivo imaging using ultra-compact Compton camera. Sci Rep. 2017 May 18;7(1):2110.
  10. Watabe T, Hanaoka K, Naka S, Kanai Y, Ikeda H, Aoki M, Shimosegawa E, Kirihata M, Hatazawa J. Practical calculation method to estimate the absolute boron concentration in tissues using (18)F-FBPA PET. Ann Nucl Med. 2017 Jul;31(6):481-485.
  11. Watabe T, Kanai Y, Ikeda H, Horitsugi G, Matsunaga K, Kato H, Isohashi K, Abe K, Shimosegawa E, Hatazawa J. Quantitative evaluation of oxygen metabolism in the intratumoral hypoxia: (18)F-fluoromisonidazole and (15)O-labelled gases inhalation PET. EJNMMI Res. 2017 Dec;7(1):16.
  12. Watabe T, Ikeda H, Nagamori S, Wiriyasermkul P, Tanaka Y, Naka S, Kanai Y, Hagiwara K, Aoki M, Shimosegawa E, Kanai Y, Hatazawa J. (18)F-FBPA as a tumor-specific probe of L-type amino acid transporter 1 (LAT1): a comparison study with (18)F-FDG and (11)C-Methionine PET. Eur J Nucl Med Mol Imaging. 2017 Feb;44(2):321-331.
  13. Momosaki S, Ito M, Yamato H, Iimori H, Sumiyoshi H, Morimoto K, Imamoto N, Watabe T, Shimosegawa E, Hatazawa J, Abe K. Longitudinal imaging of the availability of dopamine transporter and D2 receptor in rat striatum following mild ischemia. J Cereb Blood Flow Metab. 2017 Feb;37(2):605-613.